News
A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used ...
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
A leading infectious disease expert and one of the nation’s foremost COVID-19 researchers has voiced deep concerns about the ...
Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's ...
A CDC official who oversaw the agency’s Respiratory Virus Hospitalization Surveillance Network, known as RESP-NET, has resigned, citing concerns about how the data will be used to inform vaccine ...
2d
Zacks Investment Research on MSNEMA Accepts GSK's Filing for Expanded Use of RSV Vaccine ArexvyGSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to ...
A new panel of U.S. vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. will vote on flu shots that contain ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results